000 | 01201 a2200313 4500 | ||
---|---|---|---|
005 | 20250515193102.0 | ||
264 | 0 | _c20100201 | |
008 | 201002s 0 0 eng d | ||
022 | _a2040-3429 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFourie, Anne M | |
245 | 0 | 0 |
_aModulation of inflammatory disease by inhibitors of leukotriene A4 hydrolase. _h[electronic resource] |
260 |
_bCurrent opinion in investigational drugs (London, England : 2000) _cNov 2009 |
||
300 |
_a1173-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEpoxide Hydrolases _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 |
_aLeukotriene B4 _xantagonists & inhibitors |
650 | 0 | 4 |
_aRespiratory Tract Diseases _xdrug therapy |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
773 | 0 |
_tCurrent opinion in investigational drugs (London, England : 2000) _gvol. 10 _gno. 11 _gp. 1173-82 |
|
999 |
_c19265603 _d19265603 |